Therefore, isopyrrolonaphthoquinones and similar structures can be considered as possible candidates for the development of drugs in order to treat diseases related to the biological target GSK-3β, such as diabetes type 2, neurological disorders, or cancer [19,20,21]. Here, GSK3B is linked to type 2 diabetes mellitus.